PRE-MARKET INDIAN STOCKS NEWS: HCL Technologies (HCLT IS) Q4 (INR) profit rose 4.2% Y/Y to 44.88bln, revenue rose 12.3% Y/Y to 339.81bln,
Aurobindo Pharma (ARBP IS) - Co. will initiate a buyback of 5.423mln equity shares worth INR 8.0bln at INR 1,475/share from Apr. 23 to Apr. 29. (Moneycontrol)
BEML (BEML IS) - Co. secured an order from the Ministry of Defence for the supply of trawl assemblies worth INR 5.9bln. (Moneycontrol)
Cyient DLM (CYDL IS) - Co. Q4 (INR) profit fell 27.7% Y/Y to 224mln, revenue fell 13.8% Y/Y to 3.691bln. (Moneycontrol)
HCL Technologies (HCLT IS) - Co. Q4 (INR) profit rose 4.2% Y/Y to 44.88bln, revenue rose 12.3% Y/Y to 339.81bln, FY27 revenue growth guidance 1%-4% Y/Y in constant currency terms, and FY27 services revenue growth guidance 1.5%-4.5% Y/Y in constant currency terms. (Moneycontrol)
HDFC Life Insurance Company (HDFCLIFE IS) - Co. approved the re-appointment of Vibha Padalkar as Managing Director and Chief Executive Officer for five years effective Sep. 12, 2026. (Moneycontrol)
Hindustan Zinc (HZ IS) - Co.'s board will meet on Apr. 24 to consider audited standalone and consolidated Q4 and FY26 results, as well as a first interim dividend for FY27, if any. (Moneycontrol)
PNC Infratech (PNCL IS) - Co. emerged as the lowest bidder for two HAM-based national highway projects worth INR 34.83bln. (Moneycontrol)
Tata Elxsi (TELX IS) - Co. Q4 (INR) profit rose 27.8% Y/Y to 2.204bln, revenue rose 9.4% Y/Y to 9.938bln. (Moneycontrol)
National Stock Exchange - Co.'s IPO could move forward after Sebi's expert panel approved its application to settle the colocation and dark fibre cases for about INR 18bln. (Economic Times)
HCL Technologies' Q4 results showed a year-on-year profit increase of 4.2% and revenue growth of 12.3%, signaling a solid performance that beats many growth expectations amid a challenging environment. However, their FY27 revenue growth guidance of 1%-4% suggests cautious optimism, which may impact market sentiment on the stock and the broader IT sector in India, particularly regarding growth prospects and valuation adjustments.